Stock listing

NASDAQ:BDMD Baird Medical Investment Holdings Ltd Stock

Home listing (NASDAQ) of Baird Medical Investment Holdings Ltd

Follow Baird Medical Investment Holdings Ltd into a list and get an email when it puts out news.

Share price · NASDAQ:BDMD

$0.09 USD +0.01 (+13.4%)

Close on Nov 20, 2026

Past year -94.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.086 – $0.099 USDNov 20, 2026
Volume
1.60M sharesNov 20, 2026
Market cap
$2.88M USDAt the close on Nov 20, 2026 · price × 32.11M shares outstanding
52-week range
$0.073 – $3.70 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.10M USDMedian day 57,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Baird Medical Investment Holdings Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BDMD · Home$0.09 USD+0.011 (+13.4%)1,599,322$0.095$0.099$0.086$0.079Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BDMD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.09+0.011+13.4%$0.095$0.099$0.0861,599,322
$0.079-0.013-13.8%$0.094$0.094$0.0756,324,796
$0.092-0.015-13.8%$0.092$0.094$0.0894,213,292
$0.107+0.016+17.7%$0.088$0.116$0.08420,848,262
$0.091-0.017-15.7%$0.097$0.099$0.0811,488,365
$0.107+0.003+3.2%$0.104$0.109$0.091100,259,464
$0.104+0.007+7.2%$0.112$0.159$0.094151,164,832
$0.097-0.015-13.7%$0.098$0.102$0.0917,103,341
$0.112+0.024+27.7%$0.09$0.115$0.08887,127,233
$0.088-0.07-44.3%$0.107$0.115$0.08234,194,400
$0.158+0.049+45.0%$0.102$0.195$0.10380,619,600
$0.109-0.008-6.8%$0.095$0.115$0.0955,845,500
$0.117-0.021-15.2%$0.105$0.137$0.09324,835,500
$0.138-0.022-13.7%$0.196$0.196$0.073169,242,900
$0.16-0.028-14.9%$0.18$0.27$0.1339,661,700
$0.188-0.062-24.8%$0.25$0.253$0.162901,700
$0.25-0.032-11.3%$0.246$0.29$0.23392,500
$0.282-0.146-34.1%$0.342$0.456$0.2251,523,600
$0.428-0.018-4.0%$0.446$0.474$0.41158,400
$0.446-0.007-1.5%$0.45$0.475$0.44559,600
$0.453-0.023-4.8%$0.471$0.491$0.45335,600
$0.476-0.006-1.2%$0.462$0.549$0.46231,300
$0.482+0.046+10.6%$0.436$0.486$0.43657,700
$0.436-0.13-23.0%$0.569$0.60$0.40186,500
$0.566-0.034-5.7%$0.60$0.641$0.5553,900
$0.60+0.049+8.9%$0.552$0.619$0.5580,000
$0.551-0.134-19.6%$0.685$0.714$0.511127,200
$0.685-0.065-8.7%$0.678$0.731$0.67843,800
$0.75-0.02-2.6%$0.74$0.80$0.6667,200
$0.77-0.02-2.5%$0.766$0.808$0.7650,100
$0.790.000.0%$0.77$0.83$0.7767,000
$0.79+0.01+1.3%$0.74$0.812$0.7464,500
$0.78+0.037+5.0%$0.73$0.802$0.7341,400
$0.743-0.008-1.1%$0.746$0.85$0.7451,900
$0.751+0.007+0.9%$0.73$0.81$0.7348,900
$0.744-0.036-4.6%$0.77$0.821$0.74457,000
$0.78-0.018-2.3%$0.76$0.799$0.7357,800
$0.798+0.025+3.2%$0.735$0.845$0.7318,200
$0.773+0.006+0.8%$0.735$0.877$0.73546,100
$0.767-0.013-1.7%$0.761$0.82$0.7350,000
$0.78-0.01-1.3%$0.79$0.80$0.75125,400
$0.790.000.0%$0.769$0.82$0.732187,900
$0.79-0.051-6.1%$0.831$0.92$0.661226,100
$0.841-0.209-19.9%$1.02$1.04$0.744203,900
$1.05+0.01+1.0%$1.03$1.09$1.0225,300
$1.04-0.02-1.9%$1.08$1.13$1.03733,900
$1.060.000.0%$1.07$1.12$1.0451,900
$1.060.000.0%$1.06$1.09$1.0340,900
$1.06-0.04-3.6%$1.11$1.149$1.0648,300
$1.10+0.02+1.9%$1.08$1.14$1.0843,900
$1.08-0.04-3.6%$1.10$1.12$1.0519,800
$1.12+0.02+1.8%$1.11$1.15$1.0658,500
$1.10+0.01+0.9%$1.08$1.157$1.0543,300
$1.09-0.08-6.8%$1.16$1.19$1.0834,500
$1.17+0.05+4.5%$1.15$1.20$1.1049,600
$1.12-0.02-1.8%$1.11$1.14$1.0814,800
$1.14+0.04+3.6%$1.07$1.17$1.05833,500
$1.10-0.02-1.8%$1.10$1.17$1.0639,000
$1.12+0.01+0.9%$1.12$1.163$1.0824,400
$1.11-0.07-5.9%$1.14$1.21$1.1131,400
$1.18-0.02-1.7%$1.20$1.24$1.1535,400
$1.20+0.04+3.4%$1.16$1.25$1.1520,800
$1.160.000.0%$1.14$1.25$1.1419,600
$1.160.000.0%$1.16$1.24$1.1426,300
$1.16-0.03-2.5%$1.10$1.24$1.1078,700
Ticker
NASDAQ:BDMD
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Baird Medical Investment Holdings Ltd news

Baird Medical Investment Holdings Ltd on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
31 in the last 12 months · 63 in all · newest Nov 12, 2026 · oldest 2024
Decks
4 decks · latest Jun 27, 2024

Where Baird Medical Investment Holdings Ltd is listed

ListingExchangeCountryCurrency
NASDAQ:BDMD · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BDMDBOATSUnited StatesUSD

Valuation

EV/sales 0.8× against a median of 0.3×: 8th lowest of 10 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$16.81M USD
P/E
Loss
EV/sales
0.8×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
83.8%
Operating margin
−113.7%
Net margin
−121.0%
Debt to equity
0.4×
Beta vs S&P 500
-0.13

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Baird Medical Investment Holdings Ltd · NASDAQ:BDMDUS$2.88MUS$16.81Mn/a0.8×n/a0.1×−121.0%0.4×-0.13
IceCure Medical Ltd. · NASDAQ:ICCMUS$3.71M−US$3.80Mn/a−1.0×n/a0.4×−439.7%0.1×1.98
enVVeno Medical Corporation · NASDAQ:NVNOUS$3.65M−US$14.82Mn/an/an/a0.2×n/a0.0×1.12
Spineway SA · EURONEXT:ALSPWUS$3.63MUS$1.46Mn/a0.1×n/a0.1×−18.0%0.1×n/a
ScandiDos AB · OMXSTO:SDOSUS$2.84MUS$1.51Mn/a0.3×n/a0.6×−16.4%0.1×n/a
Beyond Air, Inc. · NASDAQ:XAIRUS$2.57M−US$8.48Mn/a−1.0×n/a0.5×−407.3%0.0×1.13
Tenon Medical, Inc. · NASDAQ:TNONUS$2.41M−US$4.57Mn/a−0.8×n/a0.3×−305.1%0.1×1.79
NuGen Medical Devices Inc · TSXV:NGMDUS$2.37MUS$12.62Mn/a122×n/an/an/an/a0.35
LKL International Bhd. · MYX:LKLUS$2.36MUS$4.15Mn/a0.3×n/a0.1×−46.9%0.2×n/a
RemSleep Holdings, Inc. · OTC:RMSLUS$2.09MUS$2.06Mn/a123×n/an/an/an/a-0.01
Fuse Medical, Inc. · OTC:FZMDUS$2.03MUS$4.31M14.8×0.5×7.8×0.3×1.5%0.4×0.54
Median of the othersUS$2.49MUS$1.49M14.8×0.3×7.8×0.3×−46.9%0.1×1.12

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
4.00 USD · Analysts' mean
EPS, year to Dec 2026
0.080 · 1 analyst
Revenue, year to Dec 2026
27.52M · 1 analyst

Team and board

Officers

OfficerRole
Haimei WuChairwoman of the Board and Chief Executive Officer
Quan QiuExecutive Director and Chief Administrative Officer
Wei HouExecutive Director

Board

DirectorRole
Haimei WuChairwoman of the Board and Chief Executive Officer
Gabrielle WolfsonIndependent Director
Joseph Douglas RaganDirector
Lijian XuIndependent Director
Mingzhao XingIndependent Director
Quan QiuExecutive Director and Chief Administrative Officer
Wei HouExecutive Director

Events

QuarterResultsShare move
Q3 2025Dec 5, 2025−4.9%
Q1 2025May 15, 2025−1.0%
Q3 2024Nov 15, 2024−3.2%
Quarter to Dec 31, 2022Mar 30, 2023
Quarter to Sep 30, 2022Nov 14, 2022
Quarter to Jun 30, 2022Aug 15, 2022
Quarter to Mar 31, 2022May 13, 2022
Quarter to Dec 31, 2021Mar 31, 2022
Quarter to Sep 30, 2021Oct 5, 2021

Open Events

Decks

DeckKindSlidesDate
SPAC Merger (June 2024)SPAC merger32 slidesJun 27, 2024
SPAC Merger (March 2024)SPAC merger32 slidesMar 18, 2024
SPAC Merger (January 2024)SPAC merger33 slidesJan 26, 2024
SPAC Merger (December 2023)SPAC merger33 slidesDec 12, 2023

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue22.5M37.0M31.5M35.1M27.7M18.1M12.2M
Cost of revenue3.65M4.38M4.23M7.05M4.54M2.51M1.30M
Gross profit18.9M32.7M27.2M28.0M23.2M15.6M10.9M
Research and development20.1M6.17M4.27M3.86M1.04M750.5K1.16M
Selling, general and administrative14.1M5.90M8.55M6.96M6.65M2.16M1.10M
Operating income-25.6M15.3M11.9M13.6M11.9M9.86M5.61M
Depreciation and amortization1.10M1.14M1.01M916.1K1.40M1.07M638.1K
EBITDA-24.5M16.5M12.9M14.5M13.3M10.9M6.25M
Interest expense737.4K576.4K284.3K299.3K153.9K159.5K89.6K
Income before tax-26.4M14.1M12.4M14.5M12.6M9.58M-5.85M
Income tax1.17M1.49M1.70M1.75M2.42M2.43M1.28M
Net income-27.3M12.5M10.5M12.6M11.7M7.10M-7.18M
Earnings per share, basic-0.980.570.510.491.620.99-1.00
Earnings per share, diluted-0.980.570.510.49

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents178.3K2.97M1.51M1.71M3.03M1.07M220.5K
Short-term investments295.8K120.5K197.0K407.5K65.1K36.6K
Receivables42.5M46.6M31.1M24.8M12.4M8.23M4.56M
Inventory1.09M1.30M1.14M1.29M3.06M810.1K709.5K
Current assets55.0M61.4M40.1M33.8M22.4M13.1M8.67M
Property, plant and equipment6.37M7.14M6.14M
Goodwill60.3K57.8K59.4K61.1K66.2K64.6K60.6K
Total assets69.7M78.0M56.7M42.6M26.1M17.0M11.8M
Accounts payable1.81M1.25M550.2K215.9K340.2K61.1K100.2K
Current liabilities32.4M34.6M19.0M16.0M9.77M9.25M33.6M
Long-term debt6.09M3.44M1.61M
Total debt8.72M4.45M2.43M7.44M2.93M4.05M28.9M
Total liabilities38.5M38.2M21.0M16.8M10.3M10.3M34.3M
Shareholders' equity31.4M39.7M35.8M25.8M5.20M7.21M-21.9M
Shares outstanding30.8M25.6M29.4M41.0M7.19M7.19M7.19M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-1.34M-6.31M-1.02M486.0K5.26M3.91M4.41M
Capital spending-42.3K-2.85M-2.64M-5.91M-1.39M-655.4K-983.8K
Free cash flow-1.39M-9.17M-3.66M-5.42M3.87M3.25M3.43M
Cash from investing-42.3K-2.47M-2.65M-5.92M-1.39M-2.17M1.18M
Cash from financing-1.39M10.3M3.48M4.41M-1.93M-899.1K-5.72M
Dividends paid0-5.43M
Change in cash-2.40M1.46M-200.4K-1.32M1.96M850.8K220.5K

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 16, 2026Current reportSEC
6-K · Report of a foreign issuerNov 5, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeOct 1, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
424B5 · ProspectusSep 24, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 3, 2026Current reportSEC
424B3 · ProspectusAug 18, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 18, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveAug 18, 2026Other filingsSEC
All 90 filings
FilingDateTypeFiled with
POS AM · Amendment to an effective registrationAug 6, 2026Offer documentSEC
F-3/A · Registration statement, amendedAug 6, 2026Offer documentSEC
3 · Initial statement of ownershipJul 31, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeJul 31, 2026Big-stake noticeSEC
20-F/A · Annual report, amendedJul 27, 2026Annual reportSEC
POS AM · Amendment to an effective registrationMay 22, 2026Offer documentSEC
F-3 · Registration statementMay 22, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeMay 8, 2026Big-stake noticeSEC
20-F · Annual reportApr 24, 2026Annual reportSEC
3 · Initial statement of ownershipApr 21, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 21, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 21, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 17, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 15, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 31, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 31, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 10, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 10, 2026Current reportSEC
424B3 · ProspectusJan 16, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 16, 2026Other filingsSEC
CORRESP · Letter to the SECJan 13, 2026Other filingsSEC
CORRESP · Letter to the SECDec 5, 2025Other filingsSEC
F-1/A · Registration statement, amendedDec 5, 2025Offer documentSEC
6-K · Report of a foreign issuerDec 5, 2025Current reportSEC
UPLOAD · Letter from the SECAug 20, 2025Other filingsSEC
CORRESP · Letter to the SECAug 8, 2025Other filingsSEC
F-1/A · Registration statement, amendedAug 8, 2025Offer documentSEC
20-F · Annual reportMay 15, 2025Annual reportSEC
NT 20-FApr 30, 2025Explanation requestSEC
UPLOAD · Letter from the SECFeb 3, 2025Other filingsSEC
6-K · Report of a foreign issuerJan 28, 2025Current reportSEC
CORRESP · Letter to the SECJan 17, 2025Other filingsSEC
F-1/A · Registration statement, amendedJan 17, 2025Offer documentSEC
S-8 · Registration statement for employee plansJan 10, 2025Offer documentSEC
UPLOAD · Letter from the SECDec 6, 2024Other filingsSEC
F-1 · Registration statementNov 15, 2024Offer documentSEC
6-K · Report of a foreign issuerNov 1, 2024Current reportSEC
20FR12BOct 9, 2024Other filingsSEC
CERT · Exchange's certificate of listingOct 2, 2024Other filingsSEC
6-K · Report of a foreign issuerOct 1, 2024Current reportSEC
8-A12B · Registration of shares for listing on an exchangeOct 1, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 6, 2024Other filingsSEC
425Sep 5, 2024Other filingsSEC
SEC STAFF LETTERSep 5, 2024Other filingsSEC
424B3 · ProspectusSep 5, 2024Offer documentSEC
CORRESP · Letter to the SECSep 3, 2024Other filingsSEC
CORRESP · Letter to the SECAug 26, 2024Other filingsSEC
F-4/AAug 26, 2024Offer documentSEC
UPLOAD · Letter from the SECAug 22, 2024Other filingsSEC
CORRESP · Letter to the SECAug 9, 2024Other filingsSEC
F-4/AAug 9, 2024Offer documentSEC
UPLOAD · Letter from the SECAug 1, 2024Other filingsSEC
SEC STAFF LETTERJul 30, 2024Other filingsSEC
CORRESP · Letter to the SECJul 19, 2024Other filingsSEC
F-4/AJul 19, 2024Offer documentSEC
UPLOAD · Letter from the SECJul 8, 2024Other filingsSEC
CORRESP · Letter to the SECJun 20, 2024Other filingsSEC
F-4/AJun 20, 2024Offer documentSEC
UPLOAD · Letter from the SECApr 2, 2024Other filingsSEC
425Mar 18, 2024Other filingsSEC
CORRESP · Letter to the SECMar 15, 2024Other filingsSEC
F-4/AMar 15, 2024Offer documentSEC
UPLOAD · Letter from the SECFeb 6, 2024Other filingsSEC
425Jan 26, 2024Other filingsSEC
CORRESP · Letter to the SECJan 19, 2024Other filingsSEC
F-4/AJan 19, 2024Offer documentSEC
UPLOAD · Letter from the SECDec 20, 2023Other filingsSEC
425Dec 12, 2023Other filingsSEC
CORRESP · Letter to the SECNov 28, 2023Other filingsSEC
F-4/ANov 28, 2023Offer documentSEC
425Nov 22, 2023Other filingsSEC
UPLOAD · Letter from the SECSep 20, 2023Other filingsSEC
F-4Aug 21, 2023Offer documentSEC
425Aug 1, 2023Other filingsSEC
425Aug 1, 2023Other filingsSEC
425Jun 26, 2023Other filingsSEC
425Jun 26, 2023Other filingsSEC
425Jun 26, 2023Other filingsSEC
425Jun 26, 2023Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Baird Medical Investment Holdings Ltd’s releases

Common shares
32,112,440
Fully diluted
32,112,440

Fully diluted

LineShares
Common shares32,112,440

Share count over time

CountShares
Nov 22, 202632,112,440

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Citadel165KUS$124K+110KNov 16, 2026
L1 Global Manager Pty Ltd99,248US$77,413NewNov 16, 2026
Renaissance Technologies72,400US$56,472+17,029Nov 12, 2026
Two Sigma61,261US$47,784+5,761Nov 16, 2026
UBS51,259US$39,982−7,428Nov 10, 2026
National Bank Of Canada31,400US$23,550+2,916Nov 13, 2026
Ground Swell Capital, LLC26,216US$19,662NewNov 9, 2026
Jane Street19,996US$15,596−11,578Nov 12, 2026
Geode Capital19,596US$14,697No changeNov 6, 2026
Virtu Financial LLC10,567US$8,000NewNov 17, 2026
All 13 holders
HolderSharesValueChange vs Jun 30Filed
XTX Topco Ltd10,298US$7,724−872Nov 16, 2026
Wolverine Asset Management LLC205US$160No changeNov 2, 2026
Caitong International Asset Management Co., Ltd4US$3No changeOct 29, 2026

Funds

HolderSharesValueChangeAs of
Fidelity Nasdaq Composite Index Fund25,442US$37,909No changeMay 31, 2026

Big stakes

HolderStakeSharesDate
Grand Fortune Capital (HK) Co Ltd19.10%7MOct 1, 2024
L1 Capital Global Opportunities Master Fund, Ltd.9.99%3.55MSep 24, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Joseph Douglas Ragan III
Other companies: ExcelFin Acquisition Corp (Chief Financial Officer · Oct 20, 2021 – Oct 20, 2021 · Past); Resideo Technologies, Inc. (EVP & Chief Financial Officer · Oct 3, 2018 – Jun 5, 2019 · Past)
Director · Since at least Mar 18, 2026
Gabrielle WolfsonIndependent Director · Since at least Mar 18, 2026
Haimei WuChairwoman of the Board and Chief Executive Officer · Since at least Mar 27, 2026
Jie Clara LiActing Chief Financial Officer · Since at least Apr 15, 2026
Joseph Douglas RaganDirector · Since at least Nov 5, 2026
Lijian XuIndependent Director · Since at least Apr 21, 2026
Mark SaxtonCEO of Baird Medical's U · Dec 3, 2025 – Nov 5, 2026 · Past
Mingzhao XingIndependent Director · Since at least Apr 14, 2025
Quan QiuExecutive Director and Chief Administrative Officer · Since at least Apr 21, 2026
Rongjian LuChief Technical Officer · Since at least Apr 21, 2026
All 11 people
PersonSeat
Wei HouExecutive Director · Since at least Mar 31, 2026

Open People

Log in to ask 6ix AI your own questions about Baird Medical Investment Holdings Ltd.